TY - JOUR
T1 - Incidence and Prevalence of Incarceration in a Longitudinal Cohort of Women at Risk for Human Immunodeficiency Virus in the United States, 2007-2017
AU - Knittel, Andrea K.
AU - Shook-Sa, Bonnie E.
AU - Rudolph, Jacqueline E.
AU - Edmonds, Andrew
AU - Ramirez, Catalina
AU - Cohen, Mardge H.
AU - Adedimeji, Adebola
AU - Taylor, Tonya N.
AU - Michel, Katherine G.
AU - Milam, Joel
AU - Cohen, Jennifer
AU - Donohue, Jessica D.
AU - Foster, Antonina
AU - Fischl, Margaret
AU - Konkle-Parker, Deborah
AU - Adimora, Adaora A.
N1 - Publisher Copyright:
© 2021 Mary Ann Liebert, Inc., publishers.
PY - 2021/5
Y1 - 2021/5
N2 - Background: To estimate the incidence, prevalence, frequency, and duration of incarceration and to identify risk factors for incarceration among women at risk for human immunodeficiency virus (HIV) in the United States. Methods: During semiannual study visits in a multicenter cohort study, 970 HIV sero-negative participants at risk for HIV were asked about their own incarceration (10/2007-09/2017) and incarceration of sexual partners (10/2013-09/2017). We used descriptive statistics and multivariable log-binomial regression to identify baseline predictors of incident incarceration. Results: Median follow-up time across the 970 participants was 5.5 years (IQR 3.5-9.5). Nearly half (n = 453, 46.7%) of participants were incarcerated during or before the study, and the incarceration rate was 5.5 per 100 person-years. In multivariable models, incident incarceration was associated with prior incarceration (RR 5.20, 95% CI: 3.23-8.41) and noninjection drug use (RR 1.57, 95% CI: 1.10-2.25). Conclusions: Incarceration is common for women at risk for HIV. Prevention interventions that address the complex interplay of drug use, sex exchange, and housing instability for women who have experienced incarceration have the potential to reach an important group of U.S. women at risk of HIV infection.
AB - Background: To estimate the incidence, prevalence, frequency, and duration of incarceration and to identify risk factors for incarceration among women at risk for human immunodeficiency virus (HIV) in the United States. Methods: During semiannual study visits in a multicenter cohort study, 970 HIV sero-negative participants at risk for HIV were asked about their own incarceration (10/2007-09/2017) and incarceration of sexual partners (10/2013-09/2017). We used descriptive statistics and multivariable log-binomial regression to identify baseline predictors of incident incarceration. Results: Median follow-up time across the 970 participants was 5.5 years (IQR 3.5-9.5). Nearly half (n = 453, 46.7%) of participants were incarcerated during or before the study, and the incarceration rate was 5.5 per 100 person-years. In multivariable models, incident incarceration was associated with prior incarceration (RR 5.20, 95% CI: 3.23-8.41) and noninjection drug use (RR 1.57, 95% CI: 1.10-2.25). Conclusions: Incarceration is common for women at risk for HIV. Prevention interventions that address the complex interplay of drug use, sex exchange, and housing instability for women who have experienced incarceration have the potential to reach an important group of U.S. women at risk of HIV infection.
KW - HIV risk
KW - PrEP
KW - incarceration
KW - women
UR - http://www.scopus.com/inward/record.url?scp=85105728503&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105728503&partnerID=8YFLogxK
U2 - 10.1089/jwh.2020.8417
DO - 10.1089/jwh.2020.8417
M3 - Article
C2 - 33544023
AN - SCOPUS:85105728503
SN - 1540-9996
VL - 30
SP - 694
EP - 704
JO - Journal of Women's Health
JF - Journal of Women's Health
IS - 5
ER -